Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SEAGEN-INC-10808/news/Seattle-Genetics-and-Astellas-Receive-FDA-Breakthrough-Therapy-Designation-for-PADCEV-enfortum-30019036/?utm_source=whatsapp&utm_medium=social&utm_campaign=share